Breakingviews columnists consider Bill Ackman's role in the $66 bln Actavis-Allergan deal and the denouement of Halliburton's $35 bln acquisition of Baker Hughes.
01:21
01:09
00:49
01:27
01:24
01:25
02:16
00:59
01:58
01:24
01:14
01:03
01:16
00:28
01:28
01:26
02:05
01:55
01:17
00:45
01:47
01:03
01:49
01:26
01:39
01:31
01:09
00:41
00:52
02:39
01:01
01:27
01:01
01:20
01:53
01:06
01:07
01:28
02:02
01:27
01:21
00:49
01:27
01:03
01:16
00:28
01:41
01:09
01:13
01:13
00:58
00:32
01:31
01:31
00:58
01:26
01:49
00:57
01:40
00:28
01:09
01:59
01:11
01:17
02:05
00:59
01:08
01:17
01:02
01:10
01:06
00:50
01:46
01:26
00:28
00:51
01:35
01:04
01:21
01:28
01:24
01:38
01:26
02:56
01:17
01:08
01:17
01:32
01:19
01:42
01:35
01:41
02:08
01:51
01:51
01:20
01:02
01:34
02:56
01:20
01:03
01:16
01:50
00:53
03:21
01:33
01:21
01:22
02:18
01:16
01:42
01:25
01:27
02:27
02:27
01:30
01:51
01:43
01:07
00:44